Navigation Links
SemBioSys receives milestone payments from AVAC Ltd.
Date:4/7/2008

Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) in the third quarter of 2008 in order to begin a Phase I/II clinical trial later this year. Currently, the world insulin market is estimated to be over US$7 billion per year, with the potential to double by 2012.

SemBioSys also received a $500,000 milestone payment as part of the non-dilutive funding from AVAC of up to $2.4 million for advancing the development of its wholly-owned subsidiary, Botaneco. To receive this payment, SemBioSys successfully established its Botaneco technical service and sales centre and completed work on claim substantiation for a new product application of the Hydresia(TM) ingredient. As part of this milestone, Botaneco announced earlier this year that Burt's Bees, the largest natural personal care company in North America, was using Hydresia in three of its products. The addressable market for personal care ingredients is greater than US$15 billion per year.

In return for its investment, AVAC is entitled to receive a royalty, on gross revenues derived from each of the two programs insulin and Botaneco, in arrears beginning in March 2008 and December 2009, respectively, until an aggregate return up to a maximum of two times the gross amount invested by AVAC has been remitted.

About SemBioSys Genetics Inc. (http://www.sembiosys.com)

Calgary, Alberta-based SemBioSys Genetics Inc. is a biotechnology company developing protein-based pharmaceuticals for metabolic and cardiovascular diseases. The Company's lead pharmaceutical candidates, produced in the plant host safflower, are recombinant human insulin to serve the rapidly expanding global diabetes market and Apo AI, a next generation cardiovascular drug. In addition to its pharmaceutical products, SemBioSys is developing a series of non-pharmaceutical products addressing human topical, nutritional oils and agricultural biot
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
11. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... With its latest polyacrylonitrile ... to achieve faster flow rates in comparison to nylon or polyethersulfone (PES). ... to allow easy liquid flow while trapping particulates as small as 0.2 micron ...
(Date:6/30/2015)... HAUPPAUGE, N.Y. , June 30, 2015  Custom ... provider, announced today that they are silver sponsors of ... an official PCDC sponsor, Custom is lending their support ... in low-income communities. Since its founding in ... for the primary care area.  PCDC has financed over ...
(Date:6/30/2015)... ... 2015 , ... Cannavoices , Inc., a premier legal ... and broadcast initiative. Produced by filmmakers, the multi-platform initiative aims to become not ... stories ever assembled. , Cannavoices profiles Advocates, Patients, Entrepreneurs, Growers, Investors, Ancillary ...
(Date:6/29/2015)... , June 29, 2015 BioNano Genomics, ... of top research institutes, announced today that a collaboration ... Sinai resulted in the creation of the first comprehensive ... single DNA molecule methods for sequencing and genome mapping. ... provided the comprehensive analysis of the contiguous diploid human ...
Breaking Biology Technology:New Nanofiber Membrane Provides Fast, Efficient Filtration 2Custom Computer Specialists Announces Sponsorship Of The Primary Care Development Corporation's Corporate Circle 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 2BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 3
... Sept. 9 EnVivo Pharmaceuticals today announced the appointment of ... officer. DiPalma is responsible for overall financial operations for ... "EnVivo has grown to the point where we ... broad pipeline and increasing business opportunities," said Kees Been, CEO ...
... , DURHAM, N.C., Sept. 9 Oxygen Biotherapeutics, ... is being mailed today, asks shareholders to approve a 1-for-15 reverse ... , "At last years, general annual meeting we ... bulletin board and we promised to seek a listing change as ...
... , , , SAN DIEGO, Sept. 9 ... on the treatment of obesity, today announced that the Company will be speaking ... , , , Morgan Stanley Global Healthcare ... Time: 9:45am Eastern Time, Location: Grand Hyatt Hotel, ...
Cached Biology Technology:EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer 2Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split 2
(Date:6/23/2015)... DUBLIN , June 22, 2015 ... has announced the addition of the "Body-Worn ... Share, Growth, Trends and Forecast 2014 - 2020" ... report offers strategic analysis of the global body-worn ... market has been segmented on the basis of ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 ... Produktlinie mit DNA-Tests verbessert den Analyseprozess und senkt Laborkosten ... Frankfurt Prime Standard: QIA) hat heute in den ... Investigator ® für die forensische ... Kits zur Erstellung genetischer Fingerabdrücke bieten eine integrierte Lösung ...
(Date:6/16/2015)... NEW YORK , June 16, 2015  With ... the world, security remains a top concern. The recent ... confirms the need for strong authentication within government ... HYPR Token, a biometric one-time password (OTP) authenticator, has ... Processing Standards (FIPS) 140-2 Level 3 validation for tamper ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... NEW YORK (July 1, 2008) -- Clinician-scientists from NewYork-Presbyterian ... important change to guidelines used in the care of ... that following TBI, patients should be given nutritional supplementation ... which they say can improve their chances of survival ...
... (July 1, 2008, New York, NY) The Parkinson,s Disease ... toward its 2008-2009 International Research Grants and Fellowship Program ... 19 Parkinson,s scientists, chosen on April 11 from a ... committee led by Stanley Fahn, M.D., PDF,s Scientific Director. ...
... and going green be easier if you could ... a team of Canadian industry consultants set out ... forthcoming issue of the International Journal of ... The researchers recruited twenty willing households into ...
Cached Biology News:Following traumatic brain injury, balanced nutrition saves lives 2The Parkinson's Disease Foundation awards $950,000 in seed grants 2The Parkinson's Disease Foundation awards $950,000 in seed grants 3Shrinking carbon footprints 2Shrinking carbon footprints 3
Dog polyclonal to Porcine Pancreatic Islets of Langerhans Cells ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Pig): Sonicated crude membrane fraction of porcine p...
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
Proline-serine-threonine phosphatase-interacting protein 2...
Anti-gamma Glutamyl Transferase (gammaGT) Host: mouse monoclonal Species Reactivity: human Applications: WB, IP, FC Storage: 4C...
Biology Products: